Clinical Trials Directory

Trials / Completed

CompletedNCT00714090

Repetitive Transcranial Magnetic Stimulation and Venlafaxine in Depression

Repetitive Transcranial Magnetic Stimulation Efficacy for Major Resistant Depression Compared or Associated With Venlafaxine : a Multicentric Study.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
170 (actual)
Sponsor
Club rTMS et Psychiatrie · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the efficacy of add-on therapy with repetitive Transcranial Magnetic Stimulation (rTMS) and venlafaxine in the treatment of major depressive disorders compared to venlafaxine only (the optimal medication) and to rTMS only.

Detailed description

rTMS parameters : Intensity of 120% of individually determined motor threshold; frequency : 1 Hz; 360 impulsions; on period : 1 min; off period : 30 s.

Conditions

Interventions

TypeNameDescription
OTHERactive venlafaxine and active rTMS-repetitive transcranial magnetic stimulator, Inomed and Alpine Biomedactive venlafaxine LP 75 mg : 1 capsule per day for 3 days, then 2 per day for 2 to 4 weeks, if necessary 3 per day the next 2 weeks. active rTMS : 5 sessions per week for 2 to 6 weeks
OTHERactive rTMS -repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed and sham venlafaxineactive rTMS : 5 sessions per week for 2 to 6 weeks sham venlafaxine LP 75 mg : 1 capsule per day for 3 days, then 2 per day for 2 to 4 weeks, if necessary 3 per day the next 2 weeks.
OTHERsham rTMS- repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed and active venlafaxinesham rTMS : 5 sessions per week for 2 to 6 weeks active venlafaxine LP 75 mg : 1 capsule per day for 3 days, then 2 per day for 2 to 4 weeks, if necessary 3 per day the next 2 weeks.

Timeline

Start date
2008-05-01
Primary completion
2012-07-01
Completion
2013-07-01
First posted
2008-07-14
Last updated
2013-07-19

Locations

18 sites across 2 countries: France, Monaco

Source: ClinicalTrials.gov record NCT00714090. Inclusion in this directory is not an endorsement.